Idiopathic Parkinson's disease (PD) may take decades to develop, during which many risk or protective factors may come into play to initiate the pathogenesis or modify its progression to clinical PD. The lack of understanding of this prodromal phase of PD and the factors involved has been a major hurdle in the study of PD etiology and preventive strategies. Although still controversial, the Braak and dual-hit hypotheses that PD may start peripherally in the olfactory structures and/or the gut provides a theoretical platform to identify the triggers and modifiers of PD prodromal development and progression. This is particularly true for the search of environmental causes of PD as the olfactory structures and gut are the major human mucosal i...
Parkinson's disease (PD) is a heterogeneous neurodegenerative disorder that affects an estimated 10 ...
Parkinson\u27s disease (PD) is the second most common neurodegenerative disease after Alzheimer dise...
Affecting over 10 million people worldwide, Parkinson’s disease is the second most common neurodegen...
Idiopathic Parkinson's disease (PD) may take decades to develop, during which many risk or protectiv...
Despite much effort investigating the etiology of Parkinson’s disease (PD), the causes and the exact...
Parkinson's disease (PD) is a heterogeneous neurodegenerative disorder that affects an estimated 10 ...
The exact cause of Parkinson's disease (PD), the second most prevalent neurodegenerative disease in ...
Background: Parkinson’s disease (PD) – the most common neuro-degenerative movement disorder – is con...
The dual-hit hypothesis of Parkinson's disease (PD) originally postulated that a neurotropic pathoge...
Parkinson's disease (PD) is a neurodegenerative disorder for which there is no cure. Most patients s...
Genetic factors only account for up to a third of the cases of Parkinson's disease (PD), while the r...
Background: Parkinson’s disease (PD) is the second most common neurodegenerative disorder. People wi...
Purpose of Review: Neuroinflammation plays a significant role in Parkinson’s disease (PD) etiology a...
Parkinson’s disease (PD) is a prime example of a complex and heterogeneous disorder, characterized b...
Parkinson's disease (PD) is a neurodegenerative disorder whose pathogenesis depends on a combination...
Parkinson's disease (PD) is a heterogeneous neurodegenerative disorder that affects an estimated 10 ...
Parkinson\u27s disease (PD) is the second most common neurodegenerative disease after Alzheimer dise...
Affecting over 10 million people worldwide, Parkinson’s disease is the second most common neurodegen...
Idiopathic Parkinson's disease (PD) may take decades to develop, during which many risk or protectiv...
Despite much effort investigating the etiology of Parkinson’s disease (PD), the causes and the exact...
Parkinson's disease (PD) is a heterogeneous neurodegenerative disorder that affects an estimated 10 ...
The exact cause of Parkinson's disease (PD), the second most prevalent neurodegenerative disease in ...
Background: Parkinson’s disease (PD) – the most common neuro-degenerative movement disorder – is con...
The dual-hit hypothesis of Parkinson's disease (PD) originally postulated that a neurotropic pathoge...
Parkinson's disease (PD) is a neurodegenerative disorder for which there is no cure. Most patients s...
Genetic factors only account for up to a third of the cases of Parkinson's disease (PD), while the r...
Background: Parkinson’s disease (PD) is the second most common neurodegenerative disorder. People wi...
Purpose of Review: Neuroinflammation plays a significant role in Parkinson’s disease (PD) etiology a...
Parkinson’s disease (PD) is a prime example of a complex and heterogeneous disorder, characterized b...
Parkinson's disease (PD) is a neurodegenerative disorder whose pathogenesis depends on a combination...
Parkinson's disease (PD) is a heterogeneous neurodegenerative disorder that affects an estimated 10 ...
Parkinson\u27s disease (PD) is the second most common neurodegenerative disease after Alzheimer dise...
Affecting over 10 million people worldwide, Parkinson’s disease is the second most common neurodegen...